Case Study: Hill Dermaceuticals streamlines FDA-compliant digital signatures with GlobalSign

Hill Dermaceuticals Switches to GlobalSign for Easy-to-use, FDA Compliant Digital Signatures

Hill Dermaceuticals, a pharmaceutical company, sought a more cost-effective and user-friendly digital signature solution to comply with FDA CFR 21 Part 11 regulations. Their previous vendor charged per signature, lacked integrated timestamping, and created trust issues for external documents. They turned to GlobalSign for a better solution.

GlobalSign implemented its token-based digital signature solution, which provided unlimited signatures for a flat rate. This included integrated, trusted timestamping and advanced password management to aid FDA compliance. The result was a 10x faster document access speed for employees, simplified compliance processes, and automatically trusted signatures for external partners.

Hill Dermaceuticals

Jeff Tabatabai

Director